LONDON, April 14 /PRNewswire/ -- Chiltern, a leading global research organization, announced that it has opened a new office in St. Petersburg, Russia following the recent appointment of Dr. Alexey V. Kornilov as General Manager of its Russian operations.
This office is expected to grow rapidly under the leadership of Alexey V. Kornilov, MD and will be primarily focused on supporting our Global Clinical Development brand. Dr. Kornilov brings over 10 years of clinical experience to Chiltern and is a member of the St. Petersburg Society of Anesthesiology.
Over the last few years, Chiltern has conducted many trials in Russia to fulfill sponsors' demands in the region and to take advantage of highly qualified investigator sites generating high quality data.
"The opening of our St. Petersburg office is a logical next step in Chiltern's continued growth in Central & Eastern Europe," commented Armand Czaplinski MD, MBA, Chiltern General Manager, CEE. "Today, with an ever higher number of competing trials, the pharmaceutical industry increasingly recognizes the potential of CEE countries to meet enrollment goals. The availability of trained staff and the quality of the data produced, has resulted in an increased number of FDA and EMEA approved clinical trials."
About Chiltern:
Established in 1982, Chiltern is a leading global Contract Research
Organization with extensive experience conducting and staffing
international Phase I to Phase IV clinical trials across a broad
therapeutic range for a wide variety of clients. Chiltern employs more than
1,200 people with 20 offices across the United States, Europe and in India.
Chiltern provides services including Early Phase, Global Clinical
Development, Late Phase, Biometrics, Medical and Regulatory Affairs and
Resourcing Solutions.
For More Information Contact:
Catherine Lemercier Richard Baptista
Chiltern International, Inc. Chiltern International Ltd.
2111 Palomar Airport Road 171 Bath Road
Suite 200 Slough
Carlsbad Berkshire
CA 92011 SL1 4AA
USA UNITED KINGDOM
Tel: 1 (760) 707 5025 Tel: 44 (0) 1753 512 000
Fax: 1 (760) 707 5022 Fax: 44 (0) 1753 511 116
Catherine.Lemercier@chiltern.com Richard.Baptista@chiltern.com
Chiltern: Understanding
'/>"/>
| SOURCE Chiltern Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
2. Chiltern Wins Top Prize
3. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
4. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
5. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
6. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
7. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
8. Marco Romano, MD Joins Chiltern as Medical Director, Europe
9. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
10. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
11. AVMA Opens Online Resource to General Public
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |